Plus one: another COVID-19 vaccine registered in Russia

Chileans go to the polls for referendum on new constitution

Chileans will vote on Sunday in a historic referendum on the introduction of a new constitution. The plebiscite was one of the demands...

African Americans: Children of a Lesser Economic God

The marginalization of this group costs the United States 13.6 billion euros so far this centuryThe history of the United States is, to a...

The couple ordered the cheapest wine in the house in New York, accidentally received a $ 2,000 bottle

New York is home to the renowned restaurant Balthazar in order to keep a legendary restaurateur Keith McNally, 69. He has shared an event...

Dr. Fauci: Trump does not respect the scientific information about the new coronavirus

Saying the statement was correct, he stressed that a large-scale vaccine launch would take "several months in 2021" and early use would focus on...

France expels five members of a Bosnian family for shaving their daughter after their relationship with a young Christian

France expelled five Bosnians this Saturday, family members of a Muslim adolescent who was beaten and shaved last August in punishment for her relationship...

The EpiVacCorona coronavirus vaccine, developed by the Vector Research Center, has undergone clinical trials and is registered for use in Russia. This was announced today by Russian President Vladimir Putin.

“I would like to start with something else, with the pleasant information that the Novosibirsk center“ Vector ”has registered the second Russian vaccine against coronavirus today,” Vladimir Putin said today, opening a meeting with members of the government.

We are talking about the drug “EpiVacCorona” vector action. According to Rospotrebnadzor, the vaccine has successfully passed clinical trials with volunteers, no unwanted side effects have been identified. On the eve of Deputy Prime Minister Tatyana Golikova announced that post-registration clinical trials will take place in the regions of Russia with the participation of 40 thousand volunteers, including those over 60. The first batches of EpiVacCorona – 60 thousand doses – will be produced in the near future.

Recall that the first registered Russian vaccine against coronavirus “Sputnik V” was created by the Center. Gamalei together with the Ministry of Defense. The production of the drug was launched on August 15, mass vaccination is planned in 2021.



Related Articles